Donna Armentano

This inventor holds 13 USPTO granted patents and 1 published patent application. Top assignees: Genzyme Corporation, University of Florida Research Foundation Inc.. Active years: 1997-2014.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Donna Armentano. Retrieved from https://idiyas.com/inventor/donna-armentano

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 13 (Patent Applications = 1)

% Patents Active = 76.9

Average Co-Inventor Count = 3.5

ph-index = 9

Forward Citations = 454(Granted Patents)

Location History:

Watertown, MA (US) (1997)
Belmont, MA (US) (1998 - 2008)
Cambridge, MA (US) (2014)

Company Filing History:

University of Florida Research Foundation Inc.

patents

where one patent can have more than one assignee

Years Active: 1997-2014

Loading Chart...

13 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 8758761 - Combination therapies for treating type 1 diabetes (2014-06-24),

2. 7318919 - Adenovirus vectors for gene therapy (2008-01-15),

3. 7312324 - Regulatory elements for delivery to the liver (2007-12-25),

4. 6485720 - Transgene expression systems (2002-11-26),

5. 6358507 - Transgene expression systems (2002-03-19),

6. 6100086 - Transgene expression systems (2000-08-08),

7. 6093567 - Gene therapy for cystic fibrosis (2000-07-25),

8. 5981275 - Transgene expression system for increased persistence (1999-11-09),

9. 5882877 - Adenoviral vectors for gene therapy containing deletions in the (1999-03-16),

10. 5877011 - Chimeric adenoviral vectors (1999-03-02),

11. 5824544 - Adenovirus vectors for gene therapy (1998-10-20),

12. 5707618 - Adenovirus vectors for gene therapy (1998-01-13),

13. 5670488 - Adenovirus vector for gene therapy (1997-09-23),

Title: Spotlight on Inventor Donna Armentano: Pioneering Innovations in Medicine

Introduction: Donna Armentano, an esteemed inventor based in Belmont, MA, has made remarkable contributions to the field of medical science with her pursuit of innovative solutions. With a notable portfolio of 13 patents, she continues to drive advancements that have the potential to revolutionize the treatment of various health conditions.

Latest Patents: Among her latest patents, Donna Armentano's groundbreaking work on "Combination Therapies for Treating Type 1 Diabetes" stands out. This invention focuses on utilizing combination therapies to regulate the immune response in patients, thereby offering new avenues for preventing, delaying, and even reversing the onset of type 1 diabetes. Additionally, her patent on "Adenovirus Vectors for Gene Therapy" showcases her expertise in developing gene therapy vectors, particularly beneficial for conditions like cystic fibrosis.

Career Highlights: Donna Armentano has honed her skills and expertise through substantial tenures at renowned institutions and companies. Notably, she has made significant contributions during her time at Genzyme Corporation and the University of Florida Research Foundation, Incorporated. Her professional journey reflects a strong commitment to pushing the boundaries of medical innovation and improving patient outcomes.

Collaborations: Collaboration has been a key pillar of Donna Armentano's success, with her work often intersecting with that of esteemed colleagues in the field. Notable collaborators include Richard J Gregory and Alan E Smith, whose collective expertise has enriched the innovative projects they have undertaken together. Through fruitful collaborations, Donna Armentano has been able to leverage diverse perspectives and skill sets to realize groundbreaking inventions.

Conclusion: Donna Armentano's trailblazing work in inventing novel medical solutions underscores her status as a visionary in the realm of healthcare innovation. Her dedication to developing pioneering treatments and therapies exemplifies the profound impact that inventors can have on shaping the future of medicine. As she continues to drive progress in the field, Donna Armentano remains a beacon of inspiration for aspiring inventors and innovators worldwide.

Profile summary based on public USPTO records.

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]

1 patent pending: